Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 5-year average of -10221.26%, near the high end of its 5-year range (-840333.33%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
-17376.14%
OPERATING MARGIN AVG 5Y
-10221.26%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 560 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Fractyl Health, Inc.
Market Cap
$58.97M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-17376.14%
5Y Avg
-10221.26%
Market Cap
$58.66M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$59.51M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$60.39M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-72.58%
5Y Avg
-190.10%
Market Cap
$57.33M
Operating Margin
-43.78%
TTM Avg
-33.02%
3Y Avg
-37.09%
5Y Avg
-29.30%
Market Cap
$56.10M
Operating Margin
-90740.62%
TTM Avg
-45413.43%
3Y Avg
-22706.72%
5Y Avg
-15137.81%
Market Cap
$62.78M
Operating Margin
2.49%
TTM Avg
-12.82%
3Y Avg
-6.08%
5Y Avg
-11.76%
Market Cap
$54.90M
Operating Margin
-111.45%
TTM Avg
-10696.13%
3Y Avg
-10482.04%
5Y Avg
-431164.93%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fractyl Health, Inc. (GUTS) | $58.97M | 0.00% | 0.00% | -17376.14% | -10221.26% |
| Aldeyra The (ALDX)vs › | $59.07M | 0.00% | 0.00% | 0.00% | 0.00% |
| Boundless Bio, Inc. (BOLD)vs › | $58.66M | 0.00% | 0.00% | 0.00% | 0.00% |
| MiNK Therapeutics, Inc. (INKT)vs › | $59.51M | 0.00% | 0.00% | 0.00% | 0.00% |
| Adicet Bio, Inc. (ACET)vs › | $60.39M | 0.00% | 0.00% | -72.58% | -190.10% |
| Spectral AI, Inc. (MDAI)vs › | $57.33M | -43.78% | -33.02% | -37.09% | -29.30% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $56.10M | -90740.62% | -45413.43% | -22706.72% | -15137.81% |
| InterCure Ltd. (INCR)vs › | $62.78M | 2.49% | -12.82% | -6.08% | -11.76% |
| Apollomics, Inc. (APLM)vs › | $54.90M | -111.45% | -10696.13% | -10482.04% | -431164.93% |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.95M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -840333.33% |
| 2024-09-30 | -169957.14% |
| 2024-06-30 | -53453.49% |
| 2024-03-31 | -65278.79% |
| 2023-12-31 | -185442.86% |
| 2023-09-30 | -38536.11% |
| 2023-06-30 | -16493.06% |
| 2023-03-31 | -242140.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
